Cyclodextrin Inclusion Complexes Improving Antibacterial Drug Profiles: An Update Systematic Review
Future Microbiology · 01.12.2023 · 18 (18) · 1363-1379
DOI: 10.2217/fmb-2023-0124 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Future Microbiology, online erschienen am 01.11.2023. Verfasst von Anamaria M Santos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Health Sciences, Federal University of Sergipe, Aracaju, 49060-100, Sergipe, Brazil. Hauptthemen laut MEDLINE: Cyclodextrins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Aim
The study aimed to review experimental models using cyclodextrins to improve antibacterial drugs' physicochemical characteristics and biological activities.
Methods
The following terms and their combinations were used: cyclodextrins and antibacterial agents in title or abstract, and the total study search was conducted over a period up to October 2022. The review was carried out using PubMed, Scopus and Embase databases. A total of 1580 studies were identified, of which 27 articles were selected for discussion in this review.
Results
The biological results revealed that the antibacterial effect of the inclusion complexes was extensively improved. Cyclodextrins can enhance the therapeutic effects of antibiotics already existing on the market, natural products and synthetic molecules.
Conclusion
Overall, CDs as drug-delivery vehicles have been shown to improve antibiotics solubility, stability, and bioavailability, leading to enhanced antibacterial activity. The overuse of drugs can cause bacteria to become less susceptible to them. This is known as resistance. One idea on how to tackle this resistance is by using cyclodextrins (CDs). CDs can change how drugs work, making them better at fighting bacteria. As CDs are already used in making drugs, they are a good choice for the basis of creating new drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Health Sciences, Federal University of Sergipe, Aracaju, 49060-100, Sergipe, Brazil.
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe,São Cristóvão, 49060-100, Sergipe, Brazil.
- Department of Pharmacy,Federal University of Sergipe, São Cristóvão, 49060-100, Sergipe, Brazil.
- Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
ORCID-Profile: Anamaria M Santos, José Acn Júnior, Adriano As Araújo, Lucindo Jq Júnior, Diana M Aragón, Mairim R Serafini
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Santos, A. M., Júnior, J. A., Cézar, S. V., Araújo, A. A., Júnior, L. J., Aragón, D. M., & Serafini, M. R. (2023). Cyclodextrin Inclusion Complexes Improving Antibacterial Drug Profiles: An Update Systematic Review. Future Microbiology, 18(18), 1363-1379. https://doi.org/10.2217/fmb-2023-0124
Vancouver
Santos AM, Júnior JA, Cézar SV, Araújo AA, Júnior LJ, Aragón DM, et al. Cyclodextrin Inclusion Complexes Improving Antibacterial Drug Profiles: An Update Systematic Review. Future Microbiology. 2023;18(18):1363-1379. doi:10.2217/fmb-2023-0124
BibTeX
@article{Santos2023,
author = {Santos, Anamaria M and Júnior, José Acn and Cézar, Silvia Vs and Araújo, Adriano As and Júnior, Lucindo Jq and Aragón, Diana M and Serafini, Mairim R},
title = {Cyclodextrin Inclusion Complexes Improving Antibacterial Drug Profiles: An Update Systematic Review},
journal = {Future Microbiology},
year = {2023},
volume = {18},
number = {18},
pages = {1363--1379},
doi = {10.2217/fmb-2023-0124}
}
EUVIMED